UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000007354 |
|---|---|
| Receipt number | R000008664 |
| Scientific Title | Juntendo Type 2 Diabetes and Its Complication Study |
| Date of disclosure of the study information | 2012/02/22 |
| Last modified on | 2025/03/03 09:52:34 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Juntendo Type 2 Diabetes and Its Complication Study
Acronym
Juntendo Type 2 Diabetes and Its Complication Study
Scientific Title
Juntendo Type 2 Diabetes and Its Complication Study
Scientific Title:Acronym
Juntendo Type 2 Diabetes and Its Complication Study
Region
| Japan |
Condition
Condition
Type 2 Diabetes
Classification by specialty
| Medicine in general | Endocrinology and Metabolism | Nephrology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
In this study, we conduct biomarker development to be involved in the predictions such as a nephropathy extension / macrovascular disorder, the prognosis.
Basic objectives2
Others
Basic objectives -Others
We follow and, in this study, observe the natural history in patients with diabetes.
Trial characteristics_1
Exploratory
Trial characteristics_2
Explanatory
Developmental phase
Not applicable
Assessment
Primary outcomes
Death, macrovascular disorder (cerebral infarction, cerebral hemorrhage, myocardial infarction, angina), microangiopathy (extension of diabetic nephropathy, diabetic retinopathy, dialysis induction)
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 99 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Type 2 Diabetes
Key exclusion criteria
Type 1 Diabetes
Target sample size
700
Research contact person
Name of lead principal investigator
| 1st name | Tomohito |
| Middle name | |
| Last name | Gohda |
Organization
Juntendo University Faculty of Medicine
Division name
Division of Nephrology
Zip code
113-8421
Address
2-1-1 Hongo, Bunkyo-ku, Tokyo
TEL
03-3813-3111
goda@juntendo.ac.jp
Public contact
Name of contact person
| 1st name | Tomohito |
| Middle name | |
| Last name | Gohda |
Organization
Juntendo University Faculty of Medicine
Division name
Division of Nephrology
Zip code
113-8421
Address
2-1-1 Hongo, Bunkyo-ku, Tokyo
TEL
03-3813-3111
Homepage URL
jinnaika@juntendo.ac.jp
Sponsor or person
Institute
Juntendo University Faculty of Medicine
Institute
Department
Personal name
Funding Source
Organization
none
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Juntendo University Faculty of medicine
Address
2-1-1 Hongo, Bunkyo-ku, Tokyo
Tel
03-3813-3111
kenkyu5858@juntendo.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2012 | Year | 02 | Month | 22 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
235
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2011 | Year | 11 | Month | 01 | Day |
Date of IRB
| 2011 | Year | 10 | Month | 21 | Day |
Anticipated trial start date
| 2011 | Year | 11 | Month | 01 | Day |
Last follow-up date
| 2028 | Year | 09 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We do not give the limits of the treatment to outpatient department attending staff, and it is only follow-up.
Management information
Registered date
| 2012 | Year | 02 | Month | 22 | Day |
Last modified on
| 2025 | Year | 03 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008664
